However, by comparing AT2s from disease specimens to the FMO5+ and CFTR+ AT2 signatures, we observed a reduction in the CFTR+ AT2 signature across IPF datasets, with the FMO5+ AT2 signature also depressed in one of the datasets (Fig. 5L). This evidence concerns the gene FMO5 and idiopathic pulmonary fibrosis.